Complement activation and inflammation triggered by model biomaterial surfaces

Journal of Biomedical Materials Research

Volumn 41, Issue 2, 1998, Pages 333-340

  Tang, Liping ^a   Liu, Li ^b   Elwing, Hans B ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Complement activation; Gold surfaces; Inflammatory responses; Thiols

Indexed keywords

CELLS; GOLD; SULFUR COMPOUNDS;

INFLAMMATORY RESPONSES; THIOLS;

IMPLANTS (SURGICAL);

BIOMATERIAL; COMPLEMENT COMPONENT C3B RECEPTOR; GOLD; MERCAPTOETHANOL; MERCAPTOGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; COMPLEMENT ACTIVATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; INFLAMMATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; TISSUE REACTION;

ANIMALS; BIOCOMPATIBLE MATERIALS; COBRA VENOMS; COMPLEMENT ACTIVATION; COMPLEMENT PATHWAY, ALTERNATIVE; CYSTEINE; FOREIGN-BODY REACTION; GLUTATHIONE; GLYCEROL; GOLD; INFLAMMATION; MALE; MATERIALS TESTING; MERCAPTOETHANOL; MICE; PHAGOCYTES; PROSTHESES AND IMPLANTS;

EID: 0032144460     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L     Document Type: Conference Paper

References (56)

1. P. R. Craddock, J. Fehr, A. P. Dalmasso, K. L. Brigham, and H. S. Jacob, "Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes," J. Clin. Invest., 59, 879-888 (1977).
2. R. Hallgren, P. Venge, and B. G. Danielson, "Neutrophil and eosinophil degranulation during hemodialysis are mediated by the dialyzer membrane," Nephron, 32, 329-334 (1982).
3. P. J. Spagnuolo, S. H. Bass, M. C. Smith, K. Danviriyasup, and M. J. Dunn, "Neutrophil adhesiveness during prostacyclin and heparin hemodialysis," Blood, 60, 924-929 (1982).
4. R. J. Johnson, K. E. Burhop, and D. E. Van Epps, "Infusion of ovine C5a into sheep mimics the inflammatory responses to hemodialysis," J. Lab. Clin. Med., 127, 456-469 (1996).
5. R. A. Ward, E. Klein, G. B. Harding, and K. E. Murchison, "Response of complement and neutrophils to hydrophilized synthetic membranes," Am. Soc. Artif. Intern. Org. J., 34, 334-337 (1988).
6. K. E. Burhop, R. J. Johnson, J. Simpson, D. S. Chenoweth, and J. Borgia, "Biocompatibility of hemodialysis membranes: Evaluation in an ovine model," J. Lab. Clin. Med., 121, 276-293 (1993).
7. J. Bohler, P. Kramer, O. Gotze, P. Schartz, and F. Scheler, "Leukocyte counts and complement activation during pump-driven and arteriovenous hæmofiltration," Contrib. Nephrol., 36, 15-25 (1983).
8. D. E. Hammerschmidt, D. F. Stroncek, T. K. Bowers, C. J., Lammi-Keefe, D. M. Kurth, S. A. Ozalin, D. M. Nicoloff, R. C. Lillehei, P. R. Craddock, and H. S. Jacob, "Complement activation and neutropenia occurring during cardiopulmonary bypass," J. Thorac. Cardiovasc. Surg., 81, 370-377 (1981).
9. G. A. Zimmerman and D. W. Amory, "Transpulmonary polymorphonuclear leukocyte number after cardiopulmonary bypass," Am. Rev. Respir. Dis., 126, 1097-1098 (1982).
10. T. Tamiya, M. Yamasaki, Y. Maeo, T. Yamashiro, S. Ogoshi, and S. Fujimoto, "Complement activation in cardiopulmonary bypass, with special reference to anaphylatoxin production in membrane and bubble oxygenators," Ann. Thorac. Surg., 46, 47-57 (1988).
11. P. Ryhanen, E. Herva, A. Hollman, L. Nuutinen, R. Pihlajaniemi, and E. Saarela, "Changes in peripheral blood leukocyte counts, lymphocyte subpopulations and in vitro transformation after heart valve replacement," J. Thorac. Cardiovasc. Surg., 77, 259-266 (1979).
12. M. Moczar, L. Lecerf, J. P. Mazzucotelli, and D. Loisance, "Immunoglobulins and complement deposits in mitroflow pericardial bioprosthetic heart valves - A contributing factor to structural deterioration," J. Heart Valve Dis., 5 (Suppl. 3), S276-S283 (1996).
13. M. Moczar, L. Lecerf, M. Ginat, and D. Loisance, "Complement activation is involved in the structural deterioration of bovine pericardial bioprosthetic heart valves," Am. Soc. Artif. Intern. Org. J., 42, M375-M381 (1996).
14. G. J. Stewart, P. R. Lynch, F. A. Reichle, W. G. M. Ritchie, A. Smith, and R. G. Schaub, "The adhesion of leukocytes, erythrocytes, and non-cellular material to the luminal surface of the natural and artificial blood vessel in vivo," Ann. NY Acad. Sci., 283, 179-207 (1977).
15. J. Long, S. Desantis, E. Shors, M. Uszler, C. Wuest, S. Klein, and R. White, "Thrombogenicity and the interaction of proteins, platelets and white cells," Biomater. Med. Devices Artif. Org., 11, 63-73 (1983).
16. A. D. Shepard, J. A. Gelfand, A. D. Gallow, and T. F. O'Donnell, "Complement activation by synthetic vascular prostheses," J. Vasc. Surg., 1, 829-838 (1984).
17. D. E. Hammerschmidt, P. R. Craddock, J. McCullough, R. S. Kronenberg, A. P. Dalmasso, and H. S. Jacob, "Complement activation and pulmonary leukostasis during nylon fiber filtration leukapheresis," Blood, 51, 721-730 (1978).
18. D. G. Wright and J. G. Klock, "Functional changes in neutrophils collected by filtration leukapheresis and their relationship to cellular events that occur during adherence of neutrophils to nylon fibers," Exp. Hemat., 7 (Suppl. 4), 11-23 (1979).
19. J. Janatova, A. K. Cheung, and C. J. Parker, "Biomedical polymers differ in their capacity to activate complement," Complement Inflamm., 8, 61-69 (1991).
20. J. Janatova, "C3, C5 and C3a, C4a, and C5a fragments of the complement system." Meth. Enzymol., 162, 579-625 (1988).
21. P. R. Craddock, D. Hammerschmidt, J. G. White, A. P. Dalmasso, and H. S. Jacob, "Complement (C5a) induced granulocyte aggregation in vitro: A possible mechanism of complement-mediated leukostasis and leukopenia," J. Clin. Invest., 60, 260-264 (1977).
22. C. Dahlgren, J. Hed, and O. Stendahl, "Chemotaxis of polymorphonuclear leukocytes in response to surface-bound complement derived chemoattractants generated in situ," Inflammation, 8, 201-208 (1984).
23. J. T. O'Flaherty, D. L. Kruetzer, and P. A. Ward, "Chemotactic factor influences on the aggregation, swelling and foreign surface adhesiveness of human leukocytes," Am. J. Pathol., 90, 537-550 (1978).
24. G. A. Herzlinger and R. D. Gumming, "Role of complement activation in cell adhesion to polymer blood contact surfaces," Trans. Am. Soc. Artif. Intern. Org., 26, 165-171 (1980).
25. R. D. Cumming, "Important factors affecting initial blood/ material interactions," Trans. Am. Soc. Artif. Intern. Org., 26, 304-308 (1980).
26. M. D. Kazatchkine and M. P. Carreno, "Activation of the complement system at the interface between blood and artificial surfaces," Biomaterials, 9, 30-35 (1988).
27. D. E. Chenoweth, "Complement activation produced by biomaterials," Trans. Am. Soc. Artif. Intern. Org., 32, 226-232 (1986).
28. D. E. Chenoweth, "Complement activation in extracorporeal circuits," Ann. NY Acad. Sci., 516, 306-313 (1987).
29. D. E. Chenoweth, "Complement activation produced by biomaterials," Artif. Organs, 12, 508-510 (1988).
30. R. G. Nuzzo and D. L. Allara, "Adsorption of bifunctional organic disulfides on gold surfaces," J. Am. Chem. Soc., 105, 4481-4483 (1983).
31. K. L. Prime and G. M. Whitesides, "Self-assembled organic monolayers: Model systems for studying adsorption of proteins at surfaces," Science, 252, 1164-1167 (1991).
32. P. Tengvall, M. Lestelius, B. Liedberg, and L. Lundström, "Plasma protein and antisera interactions with L-cysteine and 3-mercaptoproprionic acid monolayers on gold surfaces," Langmuir, 8, 1236-1238 (1992).
33. L. Liu and H. Elwing, "Complement activation on thiolmodified gold surfaces," J. Biomed. Mater. Res., 30, 535-541 (1996).
34. P. Tengvall, A. Askendal, and I. Lundstrom, "Complement activation by 3-mercapto-1,2-propanediol immobilized on gold surfaces," Biomaterials, 17, 1001-1007 (1996).
35. A. Ihs and B. Lieberg, "Chemisorption of L-cysteine and 3-mercaptoproprionic acid on gold and copper surfaces: An infrared reflection-adsorption study," J. Colloid Interface Sci., 144, 282-292 (1991).
36. U. Jonsson, M. Malmquvist, and I. Ronnberg, "Adsorption of immunoglobulin G, protein A, and fibronectin in the submonolayer region evaluated by a combined study of ellipsometry and radiotracer technique," J. Colloid Interface Sci., 103, 360-372 (1985).
37. J. A. de Feijter, J. Benjamins, and F. A. Veer, "Ellipsometry as a tool to study the adsorption of synthetic and biopolymers at the air-water interface," Biopolymers, 17, 1759-1801 (1978).
38. L. Tang, A. H. Lucas, and J. W. Eaton, "Inflammatory responses to implanted polymeric biomaterials: Role of surface-adsorbed immunoglobulin G," J. Lab. Clin. Med., 122, 292-300 (1993).
39. L. Tang and J. W. Eaton, "Fibrin(ogen) mediates acute inflammatory responses to biomaterials," J. Exp. Med., 178, 2147-2156 (1993)
40. C. W. Van den Berg, P. C. Aerts, and H. V. Dijk, "In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje," J. Immunol. Meth., 136, 287-294 (1991).
41. S. Wiener, S. Lendvai, B. Rogers, M. Urivetzky, and M. Meilman, "Nonimmune chemotaxis in vivo: Inhibition by complement depletion with cobra factor," Am. J. Pathol., 73, 807-816 (1973).
42. C. G. Cochrane, H. J. Muller-Eberhard, and B. S. Aikin, "Depletion of plasma complement in vivo by a protein of cobra venom: Its effect on various immunologic reactions," J. Immunol., 105, 55-69 (1970).
43. S. R. Himmelhoch, W. H. Evans, M. G. Mage, and E. A. Peterson, "Purification of myeloperoxidase from the bone marrow of the guinea pig," Biochemistry, 8, 914-921 (1969).
44. L. T. Yam, C. Y. Li, and W. H. Crosby, "Cytochemical identification of monocytes and granulocytes," Am. J. Clin. Pathol., 55, 283-290 (1971).
45. J. L. Torres, R. S. Rush, and A. R. Main, "Physical and chemical characterization of a horse serum carboxylesterase," Arch. Biochem. Biophys., 267, 271-279 (1988).
46. E. Reiner, W. N. Aldridge, and F. C. G. Hoskin, Enzymes Hydrolysing Organophosphorous Compounds, Halsted Press, New York, 1989, p. 266.
47. D. E. Chenoweth and L. W. Henderson, "Complement activation during hemodialysis: Laboratory evaluation of hemodialyzers," Artif. Organs, 11, 155-162 (1987).
48. D. E. Chenoweth, "Complement activation during hemodialysis: Clinical observation, proposed mechanism, and theoretical implication," Artif. Organs, 8, 281-287 (1984).
49. M. Mrksich, C. S. Chen, Y. N. Xia, L. E. Dike, D. E. Ingber, and G. M. Whitesides, "Controlling cell attachment on contoured surfaces with self assembled monolayers of alkanethiolates on gold," Proc. Natl. Acad. Sci. USA, 93, 10775-10778 (1996).
50. M. Mrksich and G. M. Whitesides, "Using self assembled monolayers to understand the interactions of man made surfaces with proteins and cells," Ann. Rev. Biophys. Biomol. Struct., 25, 55-78 (1996).
51. R. E. Baier and R. C. Dutton, "Initial events in interactions of blood with a foreign surface," J. Biomed. Mater. Res., 3, 191-206 (1969).
52. V. I. Sevastianov, "Role of protein adsorption in blood compatibility of polymer," CRC Crit. Rev. Biocompat., 4, 109-154 (1988).
53. J. M. Anderson, T. L. Bonfield, and N. P. Ziats, "Protein adsorption and cellular adhesion and activation on bio-medical polymers," Int. J. Artif. Org., 13, 375-382 (1990).
54. J. L. Bohnert and T. A. Horbett, "Changes in adsorbed fibrinogen and albumin interactions with polymers indicated by decreases in detergent elutability," J. Colloid Interface Sci., 111, 363-377 (1986).
55. W. G. Pitt, K. Park, and S. L. Cooper, "Sequential protein adsorption and thrombus deposition on polymer biomaterials," J. Colloid Interface Sci., 111, 343-362 (1986).
56. L. Tang, T. P. Ugarova, E. F. Plow, and J. W. Eaton, "Molecular determinants of acute inflammatory responses to biomaterials, J. Clin. Invest., 97, 1329-1334 (1996).